These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 27905474)

  • 1. Inflammatory processes in cardiovascular disease: a route to targeted therapies.
    Ruparelia N; Chai JT; Fisher EA; Choudhury RP
    Nat Rev Cardiol; 2017 Mar; 14(3):133-144. PubMed ID: 27905474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory drugs as promising cardiovascular treatments.
    Huet F; Akodad M; Fauconnier J; Lacampagne A; Roubille F
    Expert Rev Cardiovasc Ther; 2017 Feb; 15(2):109-125. PubMed ID: 28010154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.
    Zarzycka B; Nicolaes GA; Lutgens E
    Expert Rev Clin Pharmacol; 2015 May; 8(3):297-313. PubMed ID: 25843158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosis.
    Hewing B; Fisher EA
    Expert Opin Drug Discov; 2012 Mar; 7(3):207-16. PubMed ID: 22468952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
    Liberale L; Montecucco F; Schwarz L; Lüscher TF; Camici GG
    Cardiovasc Res; 2021 Jan; 117(2):411-422. PubMed ID: 32666079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice.
    Tuñón J; Bäck M; Badimón L; Bochaton-Piallat ML; Cariou B; Daemen MJ; Egido J; Evans PC; Francis SE; Ketelhuth DF; Lutgens E; Matter CM; Monaco C; Steffens S; Stroes E; Vindis C; Weber C; Hoefer IE;
    Eur J Prev Cardiol; 2018 Jun; 25(9):948-955. PubMed ID: 29759006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in coronary artery disease and acute myocardial infarction - is the stage set for novel therapies?
    Klingenberg R; Luscher TF
    Curr Pharm Des; 2012; 18(28):4358-69. PubMed ID: 22390645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and atherosclerosis: what is on the horizon?
    Ruparelia N; Choudhury R
    Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation in Atherosclerosis-No Longer a Theory.
    Libby P
    Clin Chem; 2021 Jan; 67(1):131-142. PubMed ID: 33393629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM; Silvertown JD
    J Periodontol; 2008 Aug; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian Control of Inflammatory Processes in Atherosclerosis and Its Complications.
    Steffens S; Winter C; Schloss MJ; Hidalgo A; Weber C; Soehnlein O
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1022-1028. PubMed ID: 28450299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.
    Swirski FK; Nahrendorf M
    Science; 2013 Jan; 339(6116):161-6. PubMed ID: 23307733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory therapeutics for the treatment of atherosclerosis.
    Charo IF; Taub R
    Nat Rev Drug Discov; 2011 May; 10(5):365-76. PubMed ID: 21532566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
    Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
    Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updating concepts on atherosclerotic inflammation: From pathophysiology to treatment.
    Ministrini S; Carbone F; Montecucco F
    Eur J Clin Invest; 2021 May; 51(5):e13467. PubMed ID: 33259635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.